Monte Rosa Therapeutics Inc (GLUE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | GLUE | AZN | AMGN | GILD | VRTX |
| Company | Monte Rosa Therapeutics Inc | Astrazeneca Plc ADR | Amgen Inc | Gilead Sciences Inc | Vertex Pharmaceutic |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
| Open | 23.05 | 90.14 | 325.58 | 123.80 | 435.41 |
| High | 24.48 | 91.11 | 331.34 | 126.24 | 442.38 |
| Low | 23.01 | 89.17 | 321.71 | 122.28 | 429.00 |
| Latest | 24.44 | 89.94 | 331.00 | 124.14 | 442.08 |
| Change | +0.73 | -4.45 | +0.59 | -0.77 | +0.72 |
| % Change | +3.08% | -4.71% | +0.18% | -0.62% | +0.16% |
| Volume | 1,283,400 | 11,137,301 | 2,947,800 | 9,152,601 | 1,811,300 |
| 20-Day Average Volume | 2,735,810 | 8,078,160 | 2,763,105 | 6,573,665 | 1,419,580 |
| Previous Close | 23.71 | 94.39 | 330.41 | 124.91 | 441.36 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 19.67 | 93.09 | 329.47 | 123.05 | 457.13 |
| 20-Day Raw Stochastic | 88.99% | 10.49% | 51.49% | 68.95% | 22.35% |
| 20-Day Relative Strength | 68.31 | 46.22 | 53.13 | 52.58 | 47.10 |
| Weighted Alpha | +260.26 | +31.07 | +21.09 | +29.45 | +1.55 |
| Today's Opinion | 100% Buy | 64% Buy | 80% Buy | 72% Buy | 40% Buy |
| Previous Opinion | 100% Buy | 100% Buy | 64% Buy | 72% Buy | 40% Buy |
| Last Month's Opinion | 100% Buy | 88% Buy | 72% Buy | 56% Buy | 56% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +3.04% since 01/12/26 | -3.94% since 01/12/26 | +1.68% since 01/12/26 | +1.26% since 01/12/26 | -4.02% since 01/12/26 |
| Low | 23.01 on 01/20/26 | 89.17 on 01/20/26 | 319.79 on 01/13/26 | 120.22 on 01/13/26 | 429.00 on 01/20/26 |
| High | 24.57 on 01/16/26 | 96.43 on 01/14/26 | 333.03 on 01/16/26 | 126.24 on 01/20/26 | 462.42 on 01/13/26 |
| 1-Month | |||||
| %Chg | +57.27% since 12/19/25 | -1.55% since 12/19/25 | +1.11% since 12/19/25 | -0.12% since 12/19/25 | -3.10% since 12/19/25 |
| Low | 13.69 on 01/06/26 | 89.17 on 01/20/26 | 318.21 on 01/05/26 | 116.88 on 01/05/26 | 429.00 on 01/20/26 |
| High | 25.77 on 01/08/26 | 96.51 on 01/07/26 | 343.05 on 01/07/26 | 127.41 on 12/23/25 | 487.52 on 01/07/26 |
| 3-Month | |||||
| %Chg | +147.62% since 10/20/25 | +7.24% since 10/20/25 | +9.12% since 10/20/25 | +0.84% since 10/20/25 | +5.48% since 10/20/25 |
| Low | 8.94 on 10/22/25 | 80.48 on 11/04/25 | 288.00 on 10/31/25 | 114.02 on 10/31/25 | 403.16 on 11/04/25 |
| High | 25.77 on 01/08/26 | 96.51 on 01/07/26 | 346.38 on 12/03/25 | 128.70 on 11/20/25 | 487.52 on 01/07/26 |
| 6-Month | |||||
| %Chg | +311.45% since 07/18/25 | +30.75% since 07/18/25 | +12.29% since 07/18/25 | +14.71% since 07/18/25 | -3.86% since 07/18/25 |
| Low | 4.12 on 08/08/25 | 68.61 on 07/21/25 | 269.77 on 09/26/25 | 107.75 on 07/21/25 | 362.50 on 08/11/25 |
| High | 25.77 on 01/08/26 | 96.51 on 01/07/26 | 346.38 on 12/03/25 | 128.70 on 11/20/25 | 487.52 on 01/07/26 |
| Key Statistics | |||||
| Market Capitalization, $K | 1,543,948 | 292,780,416 | 177,919,520 | 154,973,344 | 111,981,408 |
| Shares Outstanding, K | 65,118 | 3,101,816 | 538,481 | 1,240,680 | 253,719 |
| Annual Sales | 75,620,000 | 54,073,000,000 | 33,424,000,000 | 28,754,000,000 | 11,020,100,000 |
| Annual Net Income | -72,700,000 | 7,035,000,000 | 4,090,000,000 | 480,000,000 | -535,600,000 |
| Last Quarter Sales | 12,770,000 | 15,191,000,000 | 9,557,000,000 | 7,769,000,000 | 3,076,400,000 |
| Last Quarter Net Income | -27,080,000 | 2,533,000,000 | 3,216,000,000 | 3,052,000,000 | 1,082,900,000 |
| 60-Month Beta | 1.60 | 0.34 | 0.45 | 0.33 | 0.31 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.33 on 11/06/25 | 1.19 on 11/06/25 | 5.64 on 11/04/25 | 2.47 on 10/30/25 | 4.80 on 11/03/25 |
| Latest Earnings Date | 03/19/26 | 02/10/26 | 02/03/26 | 02/10/26 | 02/09/26 |
| Most Recent Dividend | N/A | 0.505 on 08/08/25 | 2.380 on 11/21/25 | 0.790 on 12/15/25 | N/A |
| Next Ex-Dividends Date | N/A | 08/08/25 | 02/13/26 | 12/15/25 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 75.25 | 20.57 | 15.09 | 14.81 | 28.67 |